Article Details

Willis-Knighton Seeks Participants for Clinical Trials of COVID-19 Treatments

Retrieved on: 2021-04-05 14:59:47

Tags for this article:

Click the tags to see associated articles and topics

Willis-Knighton Seeks Participants for Clinical Trials of COVID-19 Treatments. View article details on hiswai:

Excerpt

Regeneron's monoclonal antibody treatment has been shown to significantly shorten the duration of symptoms by four days and reduce hospitalization ...

Article found on: bossierpress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up